Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the company's next phase of growth.
Brookfield Renewable Partners (NYSE:BEP) outlined plans to expand its renewable power, energy storage and nuclear businesses as executives cited rising electricity demand, grid constraints and growing needs from data centers and artificial intelligence. Chief Executive Officer Connor Teskey said th
The agreement will support more than $3 billion in investment at Maryland's Calvert Cliffs nuclear plant, including 190 MW of new capacity expected online between 2030 and 2032.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.